N/A
Completed N=756
Views on COVID-19 and Vaccination
Source: ClinicalTrials.gov NCT04706403 ↗Enrolled (actual)
756
Serious AEs
—
Results posted
Jan 2022
Primary outcomePrimary: Number of Participants Who Became Less Hesitant About the COVID-19 Vaccine After Receiving a Physician Message — 23; 26; 43; 35 Participants
Summary
The goal of this study is to develop evidence-based messages that effectively mitigate concerns of people at risk for not being vaccinated against COVID-19, with the ultimate goal of maximizing vaccine uptake in vulnerable populations. The investigators will collect data on COVID-19 disease and vaccine knowledge, beliefs, and intent to be vaccinated from an existing online panel. Results from this data collection will be used to develop effective messages and communication strategies. The investigators will test alternate versions of messages intended to reduce vaccine hesitancy and promote vaccine uptake among vaccine-hesitant individuals. This project will ultimately result in a set of tested, evidence-derived messages about vaccination for COVID-19.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Became Less Hesitant About the COVID-19 Vaccine After Receiving a Physician Message |
23; 26; 43; 35; 40 | — |
Eligibility Criteria
Inclusion Criteria
- Adult (age 18 and over) who are members of an online panel (Prolific). Members of this panel joined the panel specifically to receive invitations to participate in research surveys and similar activities.
- Able to complete an online survey in English.
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT04706403). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.